Bill
Bill > HR2064
US HR2064
To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.
summary
Introduced
04/03/2019
04/03/2019
In Committee
04/04/2019
04/04/2019
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
116th Congress
Bill Summary
Requires drug manufacturers to provide the Department of Health and Human Services with aggregate data related to product samples of drugs, devices, biologic products, and medical supplies given to hospitals, physicians, or other medical professionals during the previous calendar year, beginning in 2023.
AI Summary
This bill amends Title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to hospitals, physicians, or other medical professionals during the previous calendar year, beginning in 2023. The bill requires manufacturers to submit aggregate data on the total quantity and value of such product samples provided to covered recipients. This information will then be made publicly available by the Department of Health and Human Services.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (2)
Last Action
Subcommittee Hearings Held. (on 05/21/2019)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/116th-congress/house-bill/2064/all-info |
| BillText | https://www.congress.gov/116/bills/hr2064/BILLS-116hr2064ih.pdf |
| Bill | https://www.congress.gov/116/bills/hr2064/BILLS-116hr2064ih.pdf.pdf |
Loading...